DrR Anderson
CLIN PROF
MD-MEDICINE
GRANTS
- GRANTPrimary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI DTU TrialAbiomed26 Mar 2024 - 26 Mar 2029
- GRANTPhase I/II Clinical Trial of Human Allogeneic Cultureexpanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs) in Patients with Ischemic Heart Failure with reduced ejection fraction (HFrEF) (CardiALLO NK1R+ MSC Trial)8Biocardia27 Jul 2023 - 26 Jul 2028
- GRANTImpella-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV TrialAbiomed19 Jul 2022 - 18 Jul 2027
- GRANTSMall Annuli Randomized To Evolut or SAPIEN TrialMedtronic Inc6 Jul 2021 - 5 Jul 2027
- GRANTEffect of Intensive Medical Treatment on Quantified Coronary Artery Plaque Components with Serial Coronary CTA in Women with Non-Obstructive CADNational Institute of Health Nhlbi30 Jun 2021 - 31 Aug 2025
- GRANTA Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 Delivery in Subjects with Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery DiseaseCaladrius Biosciences26 Feb 2021 - 27 Jul 2023
- GRANTRandomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy system in Patients with refractory chronic myocardial ischemiaBiocardia18 Dec 2020 - 17 Dec 2026
- GRANTA Phase 1/2 Trial of Direct Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector Expressing a cDNA/Genomic Hybrid of Human Vascular Endothelial Growth Factor, to the Ischemic Myocardium of Subjects with Angina Pectoris Secondary to Coronary Artery Disease that is Refractory to Drug Therapy and Unsuitable for RevascularizationXylocor Therapeutics6 Jan 2020 - 14 Dec 2023
- GRANTA Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects with HypertensionAblative Solutions12 Nov 2019 - 3 Nov 2024
- GRANTWomen’s Ischemia Syndrome Evaluation (WISE) – Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)National Institute of Health Nhlbi1 May 2019 - 28 Feb 2026
- GRANTA Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial InfarctionVentrix Inc6 Apr 2017 - 2 Sep 2023
- GRANTAspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)Patient-Centered Outcomes Research Institute22 Sep 2016 - 15 Jun 2021
- GRANTRandomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP System in Patients with Post Myocardial Infarction Heart Failure (CardiAMP Heart Failure Trial)Biocardia9 Sep 2016 - 15 May 2027
- GRANTA Randomized Evaluation oF the TriGuard™ HDH Embolic Deflection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation*keystone Heart8 Jul 2016 - 3 Apr 2017
- GRANTAffordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction StudyAstrazeneca23 Nov 2015 - 13 Oct 2018
- GRANTAFFORDABILITY AND REAL-WORLD ANTIPLATELET TREATMENT EFFECTIVENESS AFTER MYOCARDIAL INFARCTION STUDYAstrazeneca14 Oct 2015 - 11 Oct 2022
- GRANTSALUS – The Direct Flow Medical Transcatheter Aortic Valve Replacement System Pivotal Trial The Safety and Effectiveness of the Direct Flow Medical Transcatheter Aortic Valve SystemDirect Flow Medical Inc30 Sep 2015 - 31 Jul 2023
- GRANTPHASE 2 PROSPECTIVE RANDOMIZED DOUBLE BLIND SHAM CONTROLLED PARALLEL GROUP MULTI CENTER TRIAL OF AMI MULTISTEM IN ......ABT Holding Company18 Mar 2015 - 29 Nov 2022
- GRANTA Registry to Assess the Ongoing Safety for Subjects that have been Randomized and Completed a Juventas Sponsored Heart Failure Protocol under IND # 14203Juventas Therapeutics18 Sep 2014 - 18 May 2017
- GRANTA Multicenter, Randomized,Double-blind,Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Transendocardial Injection of Ixmyelocel-T in Subjects with Heart Failure due to Ischemic Dilated CardiomyopathyAastrom Biosciences27 Aug 2014 - 12 Oct 2022
- GRANTALLSTAR (ALLOGENEIC HEART STEM CELLS TO ACHIEVE MYOCARDIAL REGENERATION)Capricor, Inc9 Apr 2014 - 10 Oct 2023
- GRANTA Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults with Ischemic Heart FailureJuventas Therapeutics28 Feb 2014 - 4 Nov 2016
- GRANTANDERSON PAYROLL OPERATING ACCOUNTUniversity of Florida31 Oct 2013 - 7 Mar 2028
- GRANTRenal Denervation in Patients with Uncontrolled Hypertension SYMPLICITY HTN-3Medtronic Vascular8 Jan 2013 - 22 Apr 2017
- GRANTRENAL DENERVATION IN PATIENTS WITH UNCONTROLLED HYPERTINSION- SYMPLICITY HTN-3Medtronic Vascular23 Apr 2012 - 31 Jan 2018